Kronos Advanced Technologies, Inc. KNOS – Update
We have been tracking KNOS for several months now, and the stock has really provided us with some nice swings, as we most recently mentioned on . It is among our most exciting OTC plays of 2020 so far, and the party just keeps rolling along. Following an incredible 2000+% run that spanned from our April 20 alert on the stock catching a low of .011, all the way to KNOS’s .24 high a couple of weeks ago, we did see a bit of consolidation.
The stock came down to a low of .123 on the 17th and has been steadily climbing ever since, reaching .22 on Friday. That’s an added upswing of 79% and we will be on the lookout for the stock to test and potentially break past its previous high .24, especially in the light of the following new report out this morning linking the company to Walmart.
Los Angeles, CA, July 24, 2020 (GLOBE NEWSWIRE) — Los Angeles, CA, July 24, 2020 (GLOBE NEWSWIRE) — KRONOS ADVANCED TECHNOLOGIES, INC. (OTC MARKETS: KNOS) (“KNOS” or the “Company”), a revenue-generating, product development and production company that has significantly changed the way air is moved, filtered, and sterilized, today announced that it has been approved by the retail giant, Walmart Inc. (“Walmart”) as an online supplier at Walmart.com. The Company’s air purifiers and other unique products will be available on Walmart.com very soon. (>>View Full PR)
BioSig Technologies, Inc. BSGM
We’ve also got an update on BSGM, another stock we have been tracking since the spring that has made some really nice moves for us as well. The company is preparing to present on today’s LD Micro’s “Zooming with LD” event, so we wanted to give readers a heads up on that.
Kenneth L. Londoner, Chairman and CEO of BioSig Technologies, Inc. will be presenting an overview of the Company as well as recent developments and key highlights, including progress with PURE EP(tm) system installations, the implementation of a stockholders rights plan, BioSig’s subsidiary ViralClear Pharmaceuticals, Inc.’s (ViralClear) creation of a Scientific Advisory Board and enrollment of its Phase II clinical study of merimepodib in combination with remdesivir in adult patients with advanced COVID-19.
The BioSig presentation will take place virtually over Zoom on Monday, July 27th. Mr. Londoner will also be available for one-on-one meetings with investors on the same day.
To register for this 8 am PST presentation, click here. (>>View Full PR)
Special Note:
Investors seeking safe haven from a US Dollar faced with expected decline, and increased consumer demand from China and India are currently driving gold to record highs, with Friday bringing the highest weekly closing price on record. We have got a special gold play that we’ll be delivering to your inboxes tomorrow morning so do not miss out!
Fresh Options Ideas:
SAP 08/21 $160-170 Calls
Extended Watchlist:
SBFM, BBRW, HDVY, EGOC, DKMR